Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2020-09-08 gzbh

一般编辑决定需要多久已经快半个月了，还没决定回来。

310 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2023-11-01 水逆退散～来自广西

偏重的研究方向：肿瘤;临床
经验分享：20 Reviewer(s) invited 24 Oct 23

75 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2020-07-13 903921477_92535975

Current Status:
Editors invited
02-Jan-2020
半年过去了告诉我还没有编辑处理？

198 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2024-02-28 ms7000002072362189 来自云南省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：生物信息学
经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？

75 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2020-08-02 有心有福

修回已快一月，目前状态3 Reviewers invited，期待中

6 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2023-03-30 ms4000001456586006 来自上海

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：药理学
经验分享：12月20号初投
12月28号修改格式再投
12月29号外审
1月23号意见返回小修
2月2号修回
2月7号二审
3月27号发了邮件催了一下28号接受

158 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2022-03-25 Louischeeron

审稿速度:3.0 | 投稿命中率:50.0
经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22
太慢了啊！一直等待着！

402 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2020-05-12 123c9ba4m00(暂无昵称)

五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。

156 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2021-06-09 ms5000000834510332

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：基因组学 ; 生物信息学 ; 转录组
经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收

98 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=883667, encodeId=fd7d88366e3f, content=一般编辑决定需要多久已经快半个月了，还没决定回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Sep 08 18:15:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=802665, encodeId=6a4980266574, content=Current Status: Editors invited 02-Jan-2020 半年过去了告诉我还没有编辑处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/14/6d09fbf59ea90d4ce4ff5a5c0679a7d9.jpg, createdBy=02d52293812, createdName=903921477_92535975, createdTime=Mon Jul 13 19:21:55 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189783, encodeId=58572189e834b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学 经验分享：好奇怪，我去年11月07号投的，后面发现状态是3 reviewers accepted，awaiting their reports，现在又变成editor invited 想问这种情况有人遇到吗是表达什么，有人给编辑发过邮件咨询过审稿状态没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f59189367, createdName=ms7000002072362189, createdTime=Wed Feb 28 01:31:15 CST 2024, time=2024-02-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=805814, encodeId=204680581416, content=修回已快一月，目前状态3 Reviewers invited，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d9041945823, createdName=有心有福, createdTime=Sun Aug 02 21:44:22 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205862, encodeId=abbc1205862cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从之前的1 Reviewer(s) accepted，变成现在的1 Reviewer report received 12 Mar 22 太慢了啊！一直等待着！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcc96408213, createdName=Louischeeron, createdTime=Fri Mar 25 15:14:04 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590742, encodeId=9e39590e42cc, content=五个月了，发邮件问进度，告诉我还没找到合适的审稿人。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrwJL5ic5iaZjickicQM6uV5KDf1aIRx0jyTUXMcNFdTgnvVPxLfZAQibOmBk5oq2kUtboDwibD7ibMMsow/132, createdBy=13cc2437462, createdName=123c9ba4m00(暂无昵称), createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972051, encodeId=4b829e20515b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基因组学 ; 生物信息学 ; 转录组 经验分享：2.12 投稿 2.20 格式审查 2.28 格式审查结束 3.3 邀请审稿人 4.3 一审大修给了21天时间 5.8 二审大修21天 6.9 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca215456866, createdName=ms5000000834510332, createdTime=Wed Jun 09 06:29:55 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2023-04-14 ms7000000431018817 来自天津

指派编辑以后Peer review要几天呢？

72 13

展开13条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务